What Is the Link Between SIBO and Celiac Disease?

Small intestinal bacterial overgrowth occurs far more often in people with celiac disease than in the general population, affecting roughly one in five celiac patients according to pooled data from multiple studies. A large meta-analysis found the odds of testing positive for SIBO were about five times higher in people with celiac disease than in healthy controls. The overlap between these two conditions matters because their symptoms are nearly identical, which means SIBO can silently sabotage recovery even when someone is doing everything right on a gluten-free diet.

How Common Is SIBO in People With Celiac Disease

Two systematic reviews with pooled analyses have tried to pin down a number, and they land in the same neighborhood. One meta-analysis calculated a pooled prevalence of about 18% across more than 700 celiac patients, with the odds of SIBO roughly five-fold higher compared with healthy controls.¹ A second pooled analysis estimated a mean prevalence of about 20%, and reported even higher odds, around ten-fold, when comparing celiac patients to asymptomatic controls.² Individual studies vary widely, and the exact number depends heavily on how SIBO is tested for, but the direction is consistent: celiac disease and bacterial overgrowth are linked at rates well above what you’d expect by chance.

The numbers shift depending on who is studied. Among celiac patients who still have symptoms despite following a gluten-free diet, SIBO prevalence tends to climb. One pooled estimate put it at about 28%, compared with roughly 10% in celiac patients whose symptoms had resolved.³ That gap, while suggestive, did not quite reach statistical significance, so the relationship between persistent symptoms and SIBO positivity isn’t a settled question.

Why Celiac Disease Creates Conditions for Bacterial Overgrowth

The small intestine normally keeps its bacterial population low through a combination of stomach acid, bile, digestive enzymes, the sweeping motion of the gut wall, and an intact lining that regulates what passes through. Celiac disease disrupts several of these defenses at once. Chronic inflammation damages the intestinal lining and flattens the villi, the tiny finger-like projections that absorb nutrients. That structural damage alters the local environment in ways that can allow bacteria to accumulate where they shouldn’t.

Gut motility plays a central role. The migrating motor complex, a rhythmic contraction pattern that sweeps debris and bacteria out of the small intestine between meals, can be impaired by the chronic inflammation celiac disease causes. When that sweeping action slows or becomes disorganized, bacteria that would normally be flushed into the colon linger upstream and multiply. Several studies have also documented that celiac disease can compromise gallbladder function and reduce pancreatic enzyme output, both of which further tilt conditions in favor of bacterial overgrowth.⁴ Without enough bile and enzymes to help keep bacterial populations in check, the small intestine becomes a friendlier home for organisms that don’t belong there.

Increased intestinal permeability, often called “leaky gut” in casual conversation, is another persistent feature of celiac disease that may contribute. Even after starting a gluten-free diet, some patients retain higher-than-normal gut permeability, which can disturb the local immune environment and create conditions that favor bacterial colonization.

When a Gluten-Free Diet Does Not Fix Everything

One of the most frustrating experiences for someone with celiac disease is doing everything right, strictly avoiding gluten, and still dealing with bloating, diarrhea, abdominal pain, or fatigue. This is often called non-responsive celiac disease, and SIBO is one of the recognized causes. In a study using intestinal aspirate culture (the gold standard for diagnosing SIBO), 11% of patients with non-responsive celiac disease tested positive.⁵ That same study found SIBO in 11% of patients at initial workup and in none of the asymptomatic treated patients, suggesting a real link between active symptoms and bacterial overgrowth.

A study specifically focused on celiac patients unresponsive to a gluten-free diet found that about 31% tested positive for SIBO by breath test, compared with roughly 8% of controls.⁶ Another group reported that SIBO was common enough among their non-responsive patients that treating it with antibiotics led to symptom resolution in those cases.⁷

Interestingly, the meta-analysis data suggests that SIBO rates in non-responsive celiac patients are not dramatically higher, in a statistical sense, than in celiac patients who respond well to a gluten-free diet. The pooled odds ratio was about 1.5, but the confidence interval was wide and crossed the line of no effect.⁸ This does not mean SIBO is irrelevant to non-responsive celiac; it means that SIBO is surprisingly common in celiac disease across the board, not just in the people who are struggling. In other words, even patients doing well might harbor bacterial overgrowth without knowing it, while for others, it may be the main driver of ongoing symptoms.

Refractory Celiac Disease and Higher SIBO Rates

There is an important distinction between non-responsive celiac disease and refractory celiac disease. Non-responsive means symptoms persist despite a gluten-free diet, which has many possible causes ranging from hidden gluten exposure to lactose intolerance to SIBO. Refractory celiac disease is more severe: the intestinal damage continues despite strict gluten avoidance, and it carries a different set of risks. SIBO appears to be especially prevalent in refractory disease, with one analysis reporting rates between roughly 37% and 79% depending on the diagnostic threshold used.⁹

That same study found something reassuring in one respect: SIBO positivity was not associated with the severity of villous damage, measured by the Marsh score used to grade celiac-related intestinal injury. Patients with minimal villous damage were just as likely to have SIBO as patients with severe damage. This suggests that while SIBO can cause a lot of symptoms, it doesn’t appear to be actively worsening the structural intestinal injury caused by celiac disease itself. The two conditions can coexist and both cause trouble, but they seem to damage the gut through different mechanisms.

Why Testing for SIBO in Celiac Patients Is Complicated

Diagnosing SIBO is not straightforward in anyone, and celiac disease adds extra layers of difficulty. The two main approaches, breath tests and intestinal aspirate culture, produce quite different results. Breath tests are non-invasive and widely available, but they have well-known limitations. Culture of a small intestinal aspirate, obtained during an upper endoscopy, is considered more definitive but is invasive, expensive, and only samples one spot in the small bowel.

In celiac patients, breath tests tend to detect SIBO more often than culture does. One meta-analysis found breath test prevalence of about 21%, compared with roughly 13% for culture-based methods.¹⁰ Another study that directly compared the two tests in the same patients found agreement of only about 29%, meaning the tests frequently disagreed about whether a given patient had SIBO.¹¹

Part of the discrepancy comes from where each method looks. Aspirate culture samples bacteria at one point in the upper small intestine, while breath tests measure gases produced throughout the entire length of the gut. Bacteria living further down the small bowel might produce gases detectable on a breath test but be missed by an aspirate collected higher up. The threshold for what counts as a positive culture also matters: using the stricter cutoff of 100,000 organisms per milliliter, one study found SIBO in about 18% of celiac patients, but when the threshold was dropped to 1,000 organisms per milliliter, nearly half tested positive.¹² Which cutoff you use can make the difference between “uncommon finding” and “affects half of all patients.”

For clinicians, this diagnostic messiness creates a real dilemma. A positive breath test in a celiac patient doesn’t guarantee bacterial overgrowth is the cause of their symptoms, and a negative test doesn’t rule it out. Many doctors end up making treatment decisions based on clinical judgment, symptom patterns, and response to a trial of therapy rather than relying entirely on test results.

Methanogen Overgrowth as a Specific Pattern

One finding that has emerged from recent studies is that methane-producing organisms, not just conventional bacteria, play a significant role in celiac-associated overgrowth. In one study that performed both aspirate cultures and breath tests in celiac patients, every single positive breath test reflected intestinal methanogen overgrowth, either alone or alongside elevated hydrogen.¹³ This is worth knowing because methanogens, which are technically archaea rather than bacteria, are associated with a different symptom profile. Methane slows intestinal transit, so methanogen overgrowth tends to cause constipation rather than the diarrhea more commonly associated with bacterial SIBO.

For a celiac patient whose main complaint is constipation and bloating rather than the classic watery diarrhea, methanogen overgrowth is worth considering. It also matters because methanogens don’t respond well to all the same antibiotics used for bacterial overgrowth. Rifaximin alone may be less effective, and some clinicians combine it with other agents that target methane producers specifically. The dominance of methanogens in celiac-associated overgrowth is a relatively new observation, and it may help explain why some earlier treatment trials showed disappointing results.

Treatment and the Evidence Gap

You’d think that if SIBO is contributing to symptoms in celiac patients, treating the overgrowth with antibiotics would clearly help. Some evidence supports this: pooled data from the meta-analysis showed that antibiotic treatment of SIBO-positive celiac patients resulted in symptom improvement in roughly 96% of cases and normalization of breath tests.¹⁴ An earlier study using rifaximin for one week reported that SIBO-positive celiac patients became symptom-free after treatment.¹⁵

But the strongest type of evidence, a randomized controlled trial, tells a less encouraging story. A double-blind, placebo-controlled trial of rifaximin in celiac patients with persistent symptoms found no improvement in gastrointestinal symptom scores, regardless of whether patients had positive baseline breath tests.¹⁶ The prevalence of SIBO was no different between the rifaximin and placebo groups at follow-up. A review of the literature concluded that the clinical use of rifaximin in this population is common but poorly supported, and that breath test results may not reliably identify who will benefit from antibiotic therapy.¹⁷

How do you reconcile the optimistic open-label results with the disappointing controlled trial? A few explanations are possible. Open-label studies, where both patients and doctors know treatment is being given, are prone to placebo effects. The controlled trial may have included patients whose symptoms were actually caused by something other than SIBO, diluting any real benefit. And if methanogen overgrowth, rather than conventional bacterial overgrowth, is the dominant pattern in celiac disease, then rifaximin alone may not be the right antibiotic choice for many of these patients. The evidence is genuinely mixed, and clinicians are left to make judgment calls.

The Symptom Overlap Problem

Bloating, abdominal pain, diarrhea, gas, fatigue, and even nutrient deficiencies are hallmarks of both celiac disease and SIBO. When a celiac patient on a gluten-free diet still has these symptoms, the list of possible culprits includes accidental gluten exposure, lactose intolerance, microscopic colitis, pancreatic enzyme insufficiency, irritable bowel syndrome, and SIBO, among others. Telling these apart based on symptoms alone is essentially impossible.

This overlap is partly why clinicians recommend a systematic approach rather than jumping straight to SIBO testing. Confirming strict gluten avoidance (sometimes with a dietitian review), checking celiac antibody levels, and repeating an endoscopy to look for persistent villous damage usually come first. If those steps don’t explain the ongoing symptoms, SIBO testing enters the picture. A case series from a tertiary center in India illustrated this well: of 12 celiac patients seen over three years, two who failed to respond to a gluten-free diet turned out to have SIBO in one case and lactose intolerance in the other. Both improved after the underlying problem was addressed.¹⁸

Other Digestive Conditions That Tag Along

SIBO doesn’t exist in a vacuum in celiac patients. Several other digestive problems tend to cluster alongside celiac disease, and they can interact with SIBO in ways that complicate diagnosis and treatment. Exocrine pancreatic insufficiency, where the pancreas doesn’t produce enough digestive enzymes, is increasingly recognized as a companion condition to both celiac disease and SIBO.¹⁹ When enzyme output is low, food isn’t fully broken down, which feeds bacteria in the small intestine and can both cause and worsen SIBO. Some celiac patients benefit from pancreatic enzyme supplements even if they don’t have classic pancreatic disease.

Lactose intolerance is another frequent co-traveler. Damaged villi produce less lactase, the enzyme needed to digest lactose in dairy. The undigested lactose ferments in the gut, producing gas and diarrhea that mimic SIBO. In some cases, what looks like ongoing celiac symptoms or SIBO is actually lactose intolerance that would resolve by avoiding dairy. Compromised gallbladder function and increased intestinal permeability have also been documented in celiac patients even after years on a gluten-free diet, contributing to a digestive system that runs less efficiently overall even when the primary disease is technically under control.

Small Intestinal Fungal Overgrowth

While bacterial overgrowth gets most of the attention, a related but less studied condition is small intestinal fungal overgrowth. Recent data from celiac patients suggests that fungal overgrowth, when it does occur, almost always shows up alongside bacterial overgrowth rather than on its own.²⁰ On its own, fungal overgrowth appears to be rare in celiac disease. This is useful to know because some patients and practitioners worry about candida or other fungal overgrowth as a separate problem requiring antifungal treatment. The current evidence suggests that in most celiac patients, addressing bacterial overgrowth is the priority, and standalone fungal overgrowth is unlikely to be the culprit behind persistent symptoms.

Children With Celiac Disease

Most of the SIBO research in celiac disease has been done in adults, but children are not exempt. One of the studies included in the meta-analysis had a majority of pediatric patients, with 24 of 32 celiac patients and 32 of 52 controls falling between 0 and 18 years of age.²¹ Pediatric celiac disease can already cause growth delays and nutritional deficiencies, and the addition of SIBO could worsen malabsorption at a stage when adequate nutrition is especially critical. Unfortunately, the pediatric data is thin enough that drawing firm conclusions about how common SIBO is specifically in children with celiac disease, or how aggressively to look for it, remains difficult. For parents of a child with celiac disease who continues to have symptoms or poor growth despite a strict gluten-free diet, it’s worth raising the possibility of SIBO with a pediatric gastroenterologist, even though the testing options in kids are limited and the evidence base is still catching up.

What to Make of All This if You Have Celiac Disease

If you have celiac disease and still feel lousy on a gluten-free diet, SIBO deserves a place on the list of possible explanations, but it is one of several and not automatically the most likely. Hidden gluten exposure remains the most common reason for persistent symptoms, and verifying strict adherence with a knowledgeable dietitian should come before SIBO testing. If you do get tested for SIBO, keep in mind that breath tests and cultures often disagree, and a single negative test doesn’t necessarily rule it out.

If SIBO is confirmed, antibiotic treatment may help, but the evidence for rifaximin specifically in this population is weaker than many clinicians and patients assume. Given the dominance of methanogen overgrowth in celiac-associated SIBO, discussing treatment options that address methane producers may be worth a conversation with your gastroenterologist. Addressing related issues like pancreatic enzyme insufficiency, lactose intolerance, or impaired gut motility can also make a meaningful difference, and in some patients these co-existing problems may matter more than the SIBO itself. The messy reality is that celiac disease often leaves the gut working below capacity even when the primary disease is well managed, and fixing that usually involves peeling back several layers rather than finding one neat answer.